Literature DB >> 11275979

Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells.

M Ueda1, Y Terai, K Kumagai, K Ueki, M Kanemura, M Ueki.   

Abstract

The correlation between thymidine phosphorylase (dThdPase) expression and invasion phenotype in human uterine cervical carcinoma cells was investigated using 10 cervical carcinoma cell lines. Semi-quantitative reverse transcription-polymerase chain reaction analysis was performed to investigate the mRNA levels of dThdPase and matrix metalloproteinase (MMP)-2 with beta-actin coamplified as an internal standard. dThdPase protein expression levels were detected by highly sensitive enzyme-linked immunosorbent assay. Tumor cell migration along a gradient of substratum-bound fibronectin and invasion into reconstituted basement membrane were evaluated by haptotactic migration and invasion assay. Although dThdPase mRNA and protein expression levels differed remarkably among the cell lines, there was a statistical correlation between them (r = 0.743, p = 0.0139). dThdPase gene and protein expression levels were well correlated with the number of cells that migrated and invaded (p < 0.05). Moreover, there was a close correlation between MMP-2 gene and dThdPase gene and protein expression levels (p < 0.05). Tumor cells that produce dThdPase may have a higher invasive and metastatic potential because of their capacity to pass through tissue barriers. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275979     DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1133>3.0.co;2-s

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration.

Authors:  Jian Zhou; Yong-Sheng Xiao; Zhao-You Tang; Jia Fan; Zhi-Quan Wu; Yan Zhao; Qiong Xue; Zao-Zhuo Shen; Yin-Kun Liu; Sheng-Long Ye
Journal:  J Cancer Res Clin Oncol       Date:  2005-04-30       Impact factor: 4.553

2.  Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis.

Authors:  Hai-Tao Du; Ling-Ling Du; Xian-Ling Tang; Hong-Yan Ge; Ping Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-01       Impact factor: 3.117

Review 3.  Tumor angiogenesis and molecular target therapy in ovarian carcinomas.

Authors:  Masatsugu Ueda; Yoshito Terai; Koji Kanda; Masanori Kanemura; Mikio Takehara; Hikari Futakuchi; Hiroyuki Yamaguchi; Masayuki Yasuda; Koji Nishiyama; Minoru Ueki
Journal:  Hum Cell       Date:  2005-03       Impact factor: 4.174

Review 4.  Pharmacotherapy options for locally advanced and advanced cervical cancer.

Authors:  Alfonso Dueñas-González; Lucely Cetina; Jaime Coronel; Déborah Martínez-Baños
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

5.  Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues.

Authors:  Yoichi Kobayashi; Yasuna Wada; Tatsuru Ohara; Yoshiko Okuda; Nao Suzuki; Kiyoshi Hasegawa; Kazushige Kiguchi; Bunpei Ishizuka
Journal:  Hum Cell       Date:  2007-11       Impact factor: 4.174

6.  Radiosensitizers in cervical cancer. Cisplatin and beyond.

Authors:  Myrna Candelaria; Alicia Garcia-Arias; Lucely Cetina; Alfonso Dueñas-Gonzalez
Journal:  Radiat Oncol       Date:  2006-05-08       Impact factor: 3.481

7.  No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix.

Authors:  P Kabuubi; J A Loncaster; S E Davidson; R D Hunter; C Kobylecki; I J Stratford; C M L West
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

Review 8.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.